NCT06332755
Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT03207867
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma treatment 2 terminated NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT05931393
Sequential Treatment of Cabozantinib or Cabozantinib With Nivolumab for Advanced Renal Cell Carcinoma (RCC) treatment 2 recruiting NCT05917106
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) No drug interventions Not Available Not Available recruiting NCT03875313
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors treatment 1 / 2 terminated NCT03035630
Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma treatment 2 withdrawn NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) treatment 1 active_not_recruiting NCT02447887
Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) treatment 1 / 2 terminated NCT06577961
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients treatment 1 / 2 not_yet_recruiting NCT03891485
Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy No drug interventions Not Available Not Available recruiting NCT06259552
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors No drug interventions treatment 1 recruiting NCT02072031
Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） treatment 2 unknown_status NCT02293980
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) treatment 1 active_not_recruiting NCT00520533
Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma treatment 1 terminated NCT01666353
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy No drug interventions diagnostic 0 completed NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT00199888
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. No drug interventions diagnostic 1 completed NCT05410509
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)" No drug interventions treatment Not Available recruiting NCT00557609
Phase 2 Study in Patients With MiT Tumors treatment 2 completed NCT03549000
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. No drug interventions treatment 1 terminated NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers treatment 1 / 2 completed NCT02646748
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors treatment 1 completed NCT03260894
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) treatment 3 active_not_recruiting NCT01235962
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) treatment 3 completed NCT03634540
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) treatment 2 active_not_recruiting NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis treatment 1 terminated NCT02903914
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors treatment 1 / 2 completed NCT03955393
FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS No drug interventions Not Available Not Available completed NCT05891171
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers treatment 1 recruiting NCT03311334
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT02837991
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma No drug interventions treatment 1 terminated NCT04687969
Multimodal Machine Learning Characterization of Solid Tumors No drug interventions Not Available Not Available recruiting NCT05909995
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors treatment 1 active_not_recruiting NCT04375150
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC Not Available Not Available completed NCT01339975
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01497821
AMG 172 First in Human Study in Patients With Kidney Cancer No drug interventions treatment 1 completed NCT01402089
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients treatment 4 completed NCT00663559
Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy treatment 2 completed NCT00743054
microRNA Expression in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT00131651
ATN-161 in Advanced Renal Cell Cancer treatment 2 terminated NCT00771147
A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ® Not Available Not Available completed NCT04028245
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma treatment 0 recruiting NCT00387205
Study To Assess Long Term Safety Of Pazopanib treatment 1 completed NCT05104905
A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma treatment 1 / 2 withdrawn NCT01982097
Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Not Available Not Available completed NCT01412671
Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program Not Available Not Available completed NCT04489771
A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013) treatment 2 active_not_recruiting NCT03943771
Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor. No drug interventions basic_science Not Available withdrawn NCT02454478
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC) treatment 1 completed NCT00835978
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer treatment 2 completed NCT01649778
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma Not Available Not Available completed NCT00073307
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer treatment 3 completed NCT00325507
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma treatment 2 completed NCT04895709
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02334709
Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect. No drug interventions treatment 1 / 2 completed NCT00537056
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI diagnostic Not Available completed NCT00389285
Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma treatment 1 / 2 completed NCT00698685
Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation treatment 2 terminated NCT01712685
Imaging Studies of Kidney Cancer Using 18F-VM4-037 No drug interventions diagnostic 2 terminated NCT03109015
Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing treatment 2 completed NCT04387500
Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma treatment 2 active_not_recruiting NCT01672775
A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology treatment 1 completed NCT00891475
Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients No drug interventions treatment 1 / 2 completed NCT00445042
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer treatment 2 completed NCT05745142
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine. Not Available Not Available completed NCT00706706
Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma treatment 4 completed NCT04736706
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) treatment 3 active_not_recruiting NCT00522249
Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC treatment 1 / 2 terminated NCT05899049
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, vs Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)-China Extension Study treatment 3 active_not_recruiting NCT03226236
Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC No drug interventions treatment 2 withdrawn NCT02014636
Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018) treatment 1 completed NCT00106613
A Research Study for Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT02978118
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers) No drug interventions Not Available Not Available recruiting NCT03538717
"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC" No drug interventions Not Available Not Available completed NCT00502034
Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. treatment 3 completed NCT05127824
Autologous Dendritic Cell Vaccine in Kidney Cancer treatment 2 recruiting NCT01446224
Cardiovascular and Torsades de Pointes Monitoring for Pazopanib Not Available Not Available completed NCT03916458
REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA No drug interventions Not Available Not Available completed NCT02627963
A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) treatment 3 completed NCT00158886
Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer treatment 1 terminated NCT00816686
A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer No drug interventions treatment 1 terminated NCT04113486
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations No drug interventions Not Available Not Available unknown_status NCT00095186
Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma treatment 2 completed NCT05790122
Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma No drug interventions Not Available Not Available recruiting NCT01449825
Hepatic Monitoring for Pazopanib Not Available Not Available completed NCT00478725
Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 treatment 1 completed NCT05865730
A Study of Oncobax®-AK in Patients With Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT01728948
Sorafenib in Elderly mRCC Not Available Not Available completed NCT00282048
Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer treatment 2 completed NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT00664326
A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC treatment 2 completed NCT04295174
KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other Biomarkers No drug interventions Not Available Not Available completed NCT01024920
Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib. treatment 2 completed NCT04586231
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011) treatment 3 active_not_recruiting NCT01334073
Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors treatment 1 completed NCT00056173
Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma treatment 1 / 2 completed NCT03136627
Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC treatment 1 / 2 completed NCT00356460
Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma treatment 1 completed NCT02729194
Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma treatment 0 completed NCT02417194
Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma No drug interventions Not Available Not Available unknown_status NCT01353794
Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney Cancer Not Available Not Available withdrawn NCT00363194
A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients treatment 1 completed NCT00113529
Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma treatment 1 / 2 completed NCT00861029
VEG111485: A QTc Study of Pazopanib treatment 1 completed NCT02952989
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors treatment 1 terminated NCT05534789
Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study). No drug interventions Not Available Not Available terminated NCT03091192
Savolitinib vs. Sunitinib in MET-driven PRCC. treatment 3 active_not_recruiting NCT01492192
RGD-PET-CT in Cancer Angiogenesis diagnostic 2 terminated NCT00110344
Research Study for Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT06114940
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC treatment 2 recruiting NCT00254540
Study of SU011248 in Patients With Advanced Kidney Cancer treatment 2 completed NCT00106301
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 treatment 2 completed NCT01381601
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics) Not Available Not Available completed NCT00496301
Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC treatment 2 completed NCT02962804
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC) treatment 2 withdrawn NCT02917772
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma treatment 2 completed NCT02411968
Follow up After Cryoablation of Small Renal Masses. No drug interventions Not Available Not Available completed NCT00446368
Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer treatment 2 completed NCT00043368
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) treatment 2 completed NCT04941768
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION) No drug interventions Not Available Not Available active_not_recruiting NCT02700568
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors treatment 2 completed NCT00065468
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma treatment 3 completed NCT06194669
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells No drug interventions Not Available Not Available recruiting NCT00569946
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC) treatment 2 completed NCT03138512
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney treatment 3 completed NCT02560012
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer treatment 2 terminated NCT01064310
Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer treatment 3 completed NCT00586495
Long-term Extension From RCC Phase II (11515) treatment 2 completed NCT01381614
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS) Not Available Not Available completed NCT01411423
Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan Not Available Not Available completed NCT02324803
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients treatment 2 unknown_status NCT00044564
Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma treatment 2 completed NCT03900364
a Prospective Trial Comparing Robot-assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy No drug interventions treatment Not Available completed NCT00992121
An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma other 1 completed NCT03165721
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer treatment 2 terminated NCT00529802
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer treatment 2 completed NCT04602702
Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors No drug interventions Not Available Not Available unknown_status NCT04626479
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A) treatment 1 / 2 active_not_recruiting NCT00372853
Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell Carcinoma treatment 1 completed NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer treatment 1 terminated NCT05287945
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma treatment 1 / 2 recruiting NCT00586105
Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC) treatment 3 completed NCT00130897
Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma Not Available Not Available approved_for_marketing NCT00401583
A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes treatment 1 completed NCT00001383
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 treatment 1 completed NCT05239728
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022) treatment 3 active_not_recruiting NCT02386111
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma treatment 1 terminated NCT01015911
A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma treatment 1 completed NCT01012011
Regulatory Post Marketing Surveillance Study on Nexavar® Not Available Not Available completed NCT06222593
Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC treatment 1 / 2 not_yet_recruiting NCT01034878
Sunitinib in Metastatic Renal Cancer treatment 2 completed NCT01441388
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. treatment 1 withdrawn NCT00591188
Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens treatment 2 completed NCT00678288
A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer. treatment 2 terminated NCT00502307
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma treatment 2 completed NCT02387307
A Study of rSIFN-co in Subjects With Advanced Solid Tumors treatment 1 completed NCT05589207
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion No drug interventions Not Available Not Available recruiting NCT00043407
CPG 7909 in Patients Wih Stage IV Renal Cell Cancer treatment 1 / 2 completed NCT01107509
Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers treatment Not Available completed NCT01521715
First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma treatment 4 completed NCT02782715
Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma No drug interventions treatment 1 / 2 terminated NCT00117637
BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma treatment 2 completed NCT04060537
Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer No drug interventions Not Available Not Available unknown_status NCT02732652
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT00352859
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib treatment 4 terminated NCT01021059
A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer No drug interventions treatment 1 completed NCT00661375
BAY43-9006 Phase II Study for Renal Cell Carcinoma treatment 2 completed NCT02497599
Intraoperative Dual-modality Imaging in Renal Cell Carcinoma diagnostic 1 unknown_status NCT01398306
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. No drug interventions Not Available Not Available completed NCT01221506
Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC) treatment 0 completed NCT00448149
Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer treatment 1 / 2 completed NCT01195649
Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy Not Available Not Available terminated NCT04626518
Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B) treatment 1 / 2 active_not_recruiting NCT00720941
Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma treatment 3 completed NCT00083941
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer treatment 2 completed NCT01545817
Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma treatment 2 terminated NCT01141816
Contrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Kidney Lesions No drug interventions screening Not Available unknown_status NCT00059735
A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma treatment 2 completed NCT00265135
A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma treatment 1 / 2 completed NCT05729763
Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study No drug interventions Not Available Not Available completed NCT01056263
Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012 Not Available Not Available completed NCT00134186
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer treatment 2 completed NCT00422786
Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma treatment 2 completed NCT00492986
An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma treatment 3 completed NCT01147822
Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma treatment 2 completed NCT00716625
Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed NCT00073125
Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma treatment 2 completed NCT00267748
Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) treatment 2 completed NCT04544748
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies No drug interventions treatment 1 active_not_recruiting NCT04895748
DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies treatment 1 active_not_recruiting NCT00089648
SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma treatment 2 completed NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT01367457
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus No drug interventions Not Available Not Available completed NCT02732665
Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT00895674
Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar Not Available Not Available completed NCT00077974
A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma. treatment 2 completed NCT00854620
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer treatment 2 completed NCT00111020
Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma treatment 3 completed NCT04846920
A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018) treatment 1 active_not_recruiting NCT00618982
Sorafenib Dose Escalation in Renal Cell Carcinoma treatment 2 completed NCT00158782
Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients treatment 1 completed NCT00334282
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma treatment 3 completed NCT05462873
A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00440973
Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer treatment 2 terminated NCT01557127
Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting Not Available Not Available completed NCT01087060
Detection of Renal Malignancy of Complicated Renal Cysts No drug interventions Not Available Not Available completed NCT06111560
Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors treatment 1 terminated NCT01328691
Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus No drug interventions Not Available Not Available completed NCT00256880
Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma treatment 2 completed NCT05544929
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers treatment 1 recruiting NCT02248389
Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal Masses No drug interventions other 1 completed NCT04496089
Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC No drug interventions health_services_research 1 completed NCT00083889
SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma treatment 3 completed NCT00523640
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma treatment 2 terminated NCT01307267
A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab treatment 1 completed NCT03111901
Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer treatment 1 / 2 withdrawn NCT03671304
Mobile Intervention - Physical Activity in Cancer Treatment No drug interventions supportive_care Not Available terminated NCT00538772
An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy No drug interventions Not Available Not Available withdrawn NCT00065572
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) treatment 2 suspended NCT00516672
Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors treatment 1 completed NCT04338269
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment treatment 3 active_not_recruiting NCT00079612
Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer treatment 2 completed NCT03012581
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types treatment 2 completed NCT00923481
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... treatment 2 completed NCT04195750
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005) treatment 3 active_not_recruiting NCT00445523
Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer treatment 2 completed NCT00050323
Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer No drug interventions treatment 1 / 2 completed NCT00726323
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) treatment 2 completed NCT00927043
Study Evaluating Renal Cell Carcinoma Risk Factors No drug interventions Not Available Not Available completed NCT00842790
Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging No drug interventions Not Available Not Available completed NCT01508364
Nexavar as First Targeted Therapy in Patients With Advanced Renal Cell Carcinoma Not Available Not Available completed NCT00387764
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer treatment 3 completed NCT00244764
GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma treatment 2 completed NCT00338884
Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer treatment 2 completed NCT00622479
Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia. basic_science 1 terminated NCT03456401
Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) treatment 2 terminated NCT03455452
Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer No drug interventions Not Available Not Available active_not_recruiting NCT02423954
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) treatment 1 / 2 terminated NCT02493751
A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) treatment 1 completed NCT01598597
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) No drug interventions Not Available Not Available completed NCT04714697
Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma treatment 2 not_yet_recruiting NCT01351571
An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT04625556
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome No drug interventions Not Available Not Available recruiting NCT01122615
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) treatment 1 completed NCT00184015
Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC) treatment 1 / 2 unknown_status NCT05329532
Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer treatment 1 / 2 recruiting NCT00855452
Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors No drug interventions treatment 2 completed NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT01189370
Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer treatment 2 completed NCT02684006
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) treatment 3 completed NCT01829841
A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer treatment 2 completed NCT01246817
Temsirolimus-RCC-imaging treatment 2 unknown_status NCT01158534
Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery treatment 2 completed NCT00694096
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response diagnostic 1 completed NCT02428335
Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib No drug interventions Not Available Not Available withdrawn NCT01079286
Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers treatment 1 completed NCT02655822
Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers treatment 1 completed NCT00738530
A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy treatment 3 completed NCT03741426
WIRE - Novel Treatments in Renal Cell Cancer basic_science 2 recruiting NCT00429026
Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation treatment 2 terminated NCT02375776
Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention No drug interventions supportive_care Not Available completed NCT00304460
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer treatment 1 completed NCT04260360
Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma treatment 1 withdrawn NCT04258462
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors diagnostic 2 recruiting NCT01392729
An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA) No drug interventions Not Available Not Available completed NCT02627144
Bevacizumab in Metastatic Renal Cancer Not Available Not Available completed NCT02429440
Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides treatment 1 / 2 unknown_status NCT01507740
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients Not Available Not Available terminated NCT00509704
Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT02495103
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma treatment 1 / 2 terminated NCT04620603
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer No drug interventions treatment 1 / 2 recruiting NCT00520403
A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. treatment 2 completed NCT02923284
NANOTECH RCC Biomarkers No drug interventions Not Available Not Available completed NCT03454451
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers treatment 1 completed NCT04714983
DNX-2440 for Resectable Colorectal Liver Metastasis No drug interventions treatment 1 suspended NCT00061178
Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma treatment 3 withdrawn NCT01967407
IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy. No drug interventions treatment 1 / 2 unknown_status NCT05263609
Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib treatment 2 withdrawn NCT04969315
TT-10 as a Single Agent in Subjects With Advanced Selected Solid Tumors treatment 1 / 2 active_not_recruiting NCT05061537
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors treatment 1 terminated NCT01163552
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity No drug interventions treatment 2 completed NCT02071719
Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients No drug interventions Not Available Not Available terminated NCT02830724
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers treatment 1 / 2 recruiting NCT02212730
A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031) treatment 1 terminated NCT00796757
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC). treatment 2 completed NCT00979329
Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST No drug interventions Not Available Not Available completed NCT02459067
ImmuniCell® in Patients With Advanced Cancers No drug interventions treatment 2 terminated NCT00311467
Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma treatment 3 terminated NCT00216801
Relationship of Ochratoxin A to Upper Urologic Cancers No drug interventions Not Available Not Available completed NCT05363072
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. No drug interventions Not Available Not Available completed NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy treatment 1 / 2 recruiting NCT04040712
Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors No drug interventions treatment Not Available completed NCT00073112
A Study of ABT-751 in Patients With Renal Cell Cancer treatment 2 completed NCT00890110
Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib treatment 1 / 2 unknown_status NCT04197414
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA No drug interventions Not Available Not Available recruiting NCT01538823
Urine Proteome of Surgical Patients and Healthy Volunteers No drug interventions Not Available Not Available completed NCT00172003
Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis treatment 4 completed NCT04535921
Fear of Cancer Recurrence in Genitourinary Cancer No drug interventions Not Available Not Available completed NCT00465179
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer treatment 2 completed NCT04258813
Onco-primary Care Networking to Support TEAM-based Care No drug interventions prevention Not Available recruiting NCT04682587
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma Not Available Not Available completed NCT05418387
A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona No drug interventions health_services_research Not Available withdrawn NCT06336187
European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study) No drug interventions Not Available Not Available recruiting NCT04688333
iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma No drug interventions supportive_care Not Available withdrawn NCT01778933
Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17) No drug interventions diagnostic 0 completed NCT03692533
Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma No drug interventions diagnostic Not Available unknown_status NCT02835833
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors treatment 1 completed NCT02306954
Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer treatment 2 active_not_recruiting NCT02982954
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer treatment 4 completed NCT04977453
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors treatment 1 / 2 recruiting NCT02883153
Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma diagnostic 2 / 3 completed NCT06546553
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. treatment 1 / 2 not_yet_recruiting NCT00617253
Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients treatment 2 completed NCT05518253
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00729053
Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma treatment 2 completed NCT03259477
RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC No drug interventions prevention Not Available unknown_status NCT05056077
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) No drug interventions supportive_care Not Available recruiting NCT03050047
A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO No drug interventions treatment 3 recruiting NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT01865747
A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma treatment 3 completed NCT03341845
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC treatment 2 recruiting NCT02983045
A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors treatment 1 / 2 completed NCT05887245
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy No drug interventions Not Available Not Available recruiting NCT00923845
Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer treatment 2 completed NCT03961698
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma treatment 2 active_not_recruiting NCT03987698
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma treatment 2 unknown_status NCT00490698
Zoledronate With Atorvastatin in Renal Cell Carcinoma treatment 2 completed NCT01240005
Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma No drug interventions treatment 1 / 2 unknown_status NCT04540705
A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread treatment 1 completed NCT06234605
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma treatment 1 recruiting NCT05843305
A Study of BPI-452080 in Subjects With Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT02886897
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT00574483
Treatment of Advanced Renal Cell Carcinoma With Quinacrine treatment 2 withdrawn NCT03294083
A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma treatment 1 / 2 active_not_recruiting NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT05705583
A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma No drug interventions Not Available Not Available recruiting NCT05700461
Drug Screening Using Novel IMD in Renal Cell Carcinoma No drug interventions treatment 1 recruiting NCT02763761
An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo treatment 2 withdrawn NCT06032728
Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment treatment Not Available not_yet_recruiting NCT02208128
Molecular Determinants for Therapy Response on Renal Cell Carcinoma treatment Not Available unknown_status NCT00731211
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT01720693
Novel Controlled Hypo-Perfusion Technique in Partial Nephrectomy No drug interventions prevention 2 terminated NCT01216371
Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) treatment 2 unknown_status NCT05486871
Oncological and Functional Outcomes of Laparoscopic Partial Nephrectomy in Renal Cell Carcinoma Stages T1 Versus T2a: Prospective Comparative Study. No drug interventions treatment Not Available unknown_status NCT04974671
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma No drug interventions treatment 2 recruiting NCT02138578
Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma No drug interventions treatment Not Available terminated NCT01062178
Efficacy of Ultrasound Contrast Agent to Assess Renal Masses diagnostic 2 completed NCT04510688
Spanish Real-World Evidence Cabozantinib Not Available Not Available completed NCT06438588
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial No drug interventions supportive_care Not Available recruiting NCT06317207
Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy No drug interventions Not Available Not Available completed NCT06383507
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT04177056
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief No drug interventions treatment Not Available unknown_status NCT03629756
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies treatment 1 completed NCT05638256
68Ga-labeled NY104 PET Imaging in Patients No drug interventions diagnostic 0 recruiting NCT00100685
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) treatment 2 terminated NCT02089685
Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29) treatment 1 / 2 completed NCT03667885
Non-Invasive Diagnostics of Small Renal Masses No drug interventions Not Available Not Available unknown_status NCT00753415
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) No drug interventions treatment 1 completed NCT06444815
A Study of VET3-TGI in Patients With Solid Tumors treatment 1 not_yet_recruiting NCT05319015
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus treatment 2 recruiting NCT05070637
Circulating Tumor Cell Reducing No-touch Nephrectomy No drug interventions treatment Not Available completed NCT02677337
NCCN Renal Cell Registry No drug interventions other Not Available completed NCT01002937
Novel Prognostic Markers in Renal Cancer No drug interventions Not Available Not Available completed NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors treatment 1 recruiting NCT00423332
Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma treatment 2 completed NCT02162732
Molecular-Guided Therapy for Childhood Cancer No drug interventions treatment Not Available completed NCT03288532
Renal Adjuvant MultiPle Arm Randomised Trial treatment 3 recruiting NCT02223052
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies treatment 1 completed NCT05785052
Biomarkers of Renal Cancer No drug interventions Not Available Not Available recruiting NCT01176552
Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer treatment 2 completed NCT02671552
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery diagnostic 0 withdrawn NCT02160600
Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial No drug interventions diagnostic Not Available completed NCT04609800
Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France. No drug interventions Not Available Not Available withdrawn NCT06134700
Low Pressure Versus Standard Pressure Pneumoperitoneum in Laparoscopic Nephrectomy No drug interventions other Not Available not_yet_recruiting NCT04088500
A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma treatment 2 terminated NCT00082459
Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT01892059
Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy No drug interventions treatment Not Available unknown_status NCT04989959
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma diagnostic 1 recruiting NCT05769959
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors treatment 1 terminated NCT04960059
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts No drug interventions Not Available Not Available recruiting NCT00523159
IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease treatment 2 completed NCT04077359
Prospective Trial for Examining Hematuria Using Computed Tomography No drug interventions diagnostic Not Available completed NCT04691375
A Study of PY314 in Subjects With Advanced Solid Tumors treatment 1 terminated NCT04262375
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION treatment 2 withdrawn NCT00199875
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 treatment 1 completed NCT00782275
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma treatment 2 completed NCT00491075
Pemetrexed Plus Gemcitabine in Renal Cell Cancer treatment 2 terminated NCT00513175
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia No drug interventions Not Available Not Available completed NCT04337970
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer treatment 1 / 2 active_not_recruiting NCT06453642
Evaluation of a Simple-Prep Controlled Embolic No drug interventions treatment Not Available not_yet_recruiting NCT01781442
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration Not Available Not Available withdrawn NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT05013099
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies diagnostic 2 active_not_recruiting NCT02762006
Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma treatment 1 completed NCT02009449
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00272649
Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer treatment 1 / 2 completed NCT03094949
Comparison Between Partial Nephrectomy and Ablation for Renal Tumor No drug interventions treatment Not Available unknown_status NCT01482949
A Rollover Protocol for Subjects Previously Treated With AGS-003 treatment 2 terminated NCT06523049
Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy treatment 2 not_yet_recruiting NCT01625936
CRLX101 Plus Bevacizumab in Advanced RCC treatment 1 completed NCT03630536
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative No drug interventions Not Available Not Available recruiting NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04580836
MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial No drug interventions treatment 2 withdrawn NCT00036036
Study of CP-461 in Patients With Advanced Renal Cell Cancer No drug interventions treatment 2 completed NCT02473536
Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC No drug interventions treatment 1 / 2 active_not_recruiting NCT03655613
APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC treatment 1 / 2 terminated NCT03343613
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors No drug interventions treatment 1 terminated NCT04152018
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. No drug interventions treatment 1 active_not_recruiting NCT05188118
Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma treatment 0 recruiting NCT03937219
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma treatment 3 active_not_recruiting NCT04704219
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61) treatment 2 active_not_recruiting NCT05420519
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer No drug interventions treatment 1 recruiting NCT02795819
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer treatment 1 terminated NCT02613819
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney No drug interventions treatment 2 active_not_recruiting NCT00678119
Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment treatment 2 completed NCT01272817
Nonmyeloablative Allogeneic Transplant No drug interventions treatment Not Available completed NCT02030717
Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma treatment 2 / 3 completed NCT00113217
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma treatment 2 completed NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma treatment 1 recruiting NCT04309617
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy No drug interventions Not Available Not Available completed NCT03142334
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564) treatment 3 active_not_recruiting NCT00609934
Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone Not Available 1 / 2 completed NCT03948724
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology No drug interventions prevention Not Available active_not_recruiting NCT04995016
Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma treatment 2 unknown_status NCT03494816
Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion treatment 2 completed NCT00277316
Study of XL999 in Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT03024996
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy treatment 3 terminated NCT05293496
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT05830058
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma No drug interventions treatment 2 recruiting NCT06053658
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma treatment 2 recruiting NCT02075658
A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation No drug interventions supportive_care Not Available completed NCT02533258
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice No drug interventions Not Available Not Available completed NCT05641935
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation diagnostic 2 recruiting NCT05119335
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 / 2 recruiting NCT01331135
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors treatment 1 completed NCT00480935
A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma treatment 2 terminated NCT02432963
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy treatment 1 active_not_recruiting NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04792463
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome No drug interventions Not Available Not Available recruiting NCT04798963
The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy No drug interventions treatment Not Available unknown_status NCT03033186
Everolimus TDM to Predict Long Term Toxicity No drug interventions Not Available Not Available unknown_status NCT00474786
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib treatment 3 completed NCT01070186
Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma treatment 2 withdrawn NCT02687139
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma diagnostic Not Available completed NCT02940639
Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy No drug interventions Not Available Not Available active_not_recruiting NCT05783622
Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT00854022
Genetic Susceptibility to Kidney Cancer No drug interventions Not Available Not Available terminated NCT05721222
PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001) No drug interventions treatment 1 / 2 recruiting NCT04913025
REduced Frequency ImmuNE Checkpoint Inhibition in Cancers treatment 2 recruiting NCT05037825
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors No drug interventions Not Available Not Available recruiting NCT06554730
Merck Belzutifan PAS No drug interventions Not Available Not Available not_yet_recruiting NCT04040530
Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours No drug interventions Not Available Not Available active_not_recruiting NCT03502330
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma treatment 1 completed NCT01283048
Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma treatment 1 completed NCT00831857
VEGF Imaging in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT00340457
Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States No drug interventions Not Available Not Available completed NCT03798626
Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers treatment 1 active_not_recruiting NCT05023265
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT No drug interventions treatment Not Available not_yet_recruiting NCT00898365
Study of Kidney Tumors in Younger Patients No drug interventions Not Available Not Available recruiting NCT02498665
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies treatment 1 completed NCT05012865
Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART) Not Available Not Available completed NCT01887574
Renal Mass Registry No drug interventions other Not Available completed NCT00601120
RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma No drug interventions treatment Not Available withdrawn NCT01838720
Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage No drug interventions treatment Not Available unknown_status NCT05326620
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) No drug interventions Not Available Not Available recruiting NCT01291420
Dendritic Cell Vaccination for Patients With Solid Tumors No drug interventions treatment 1 / 2 completed NCT04267120
Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial) treatment 2 active_not_recruiting NCT04666220
VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma No drug interventions Not Available Not Available unknown_status NCT03621982
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors treatment 1 terminated NCT06099782
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11) treatment 2 recruiting NCT01041482
A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma treatment 2 unknown_status NCT04134182
Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment. treatment 2 unknown_status NCT05653882
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors treatment 1 recruiting NCT00378482
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. treatment 2 completed NCT01034631
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma treatment 1 / 2 completed NCT04146831
Sintilimab in FH-deficient Renal Cell Carcinoma treatment 2 unknown_status NCT02747173
Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques No drug interventions Not Available Not Available terminated NCT04958473
A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer treatment 2 not_yet_recruiting NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT04883827
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00323076
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours diagnostic 1 / 2 terminated NCT04570176
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System No drug interventions treatment Not Available completed NCT06055660
Moesin Expression in Clear Cell Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT06034860
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types treatment 1 recruiting NCT04669860
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma No drug interventions Not Available Not Available recruiting NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor Not Available Not Available available NCT05738694
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma treatment 2 recruiting NCT02585362
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program No drug interventions supportive_care Not Available completed NCT02853162
Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study) No drug interventions treatment 2 terminated NCT03029780
An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma treatment 2 completed NCT04510129
A Multicenter Cancer Biospecimen Collection Study No drug interventions Not Available Not Available recruiting NCT00480389
Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal treatment 2 completed NCT04163289
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation treatment 1 active_not_recruiting NCT00030992
BMS 247550 to Treat Kidney Cancer treatment 2 completed NCT03670992
Surgical Treatment of Pancreatic RCC Metastases No drug interventions Not Available Not Available completed NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures No drug interventions device_feasibility Not Available enrolling_by_invitation NCT06182644
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors No drug interventions diagnostic Not Available recruiting NCT02776644
Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan No drug interventions Not Available Not Available completed NCT02853344
Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427) treatment 2 completed NCT02072044
Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy treatment 2 unknown_status NCT00422344
A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma treatment 1 completed NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT04341740
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma No drug interventions other Not Available terminated NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT05837767
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue No drug interventions treatment Not Available recruiting NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer treatment 1 / 2 active_not_recruiting NCT00609401
Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC) treatment 2 completed NCT00353301
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma treatment 2 completed NCT01466504
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin No drug interventions Not Available Not Available terminated NCT03052504
Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy No drug interventions Not Available Not Available completed NCT00033904
Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer treatment 3 completed NCT01582672
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma treatment 3 terminated NCT04424472
Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma No drug interventions diagnostic Not Available unknown_status NCT03592472
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) treatment 3 recruiting NCT06093568
Delving Into Participation Trends in Renal Cell Carcinoma Studies No drug interventions Not Available Not Available not_yet_recruiting NCT01253668
Brivanib Metastatic Renal Cell Carcinoma treatment 2 terminated NCT05941169
Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy No drug interventions treatment Not Available not_yet_recruiting NCT05703269
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy No drug interventions supportive_care Not Available recruiting NCT01144169
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma treatment 1 terminated NCT01798446
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus treatment 2 completed NCT00953446
Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma No drug interventions diagnostic Not Available terminated NCT00610012
Tumor Registry of Advanced Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT05739812
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery No drug interventions other Not Available recruiting NCT05048212
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases treatment 2 recruiting NCT01265810
Caphosol in Oral Mucositis Due to Targeted Therapy No drug interventions supportive_care 3 completed NCT03323710
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma treatment 2 withdrawn NCT02082210
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer treatment 1 / 2 completed NCT03758781
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors treatment 1 completed NCT03501381
High Dose IL 2 and Entinostat in RCC treatment 2 active_not_recruiting NCT00918281
Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection diagnostic 2 completed NCT06472895
A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma treatment 1 / 2 not_yet_recruiting NCT02005614
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection No drug interventions treatment Not Available terminated NCT00732914
Sequential Study to Treat Renal Cell Carcinoma treatment 3 completed NCT02989714
Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer treatment 1 / 2 completed NCT05024214
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors treatment 1 / 2 recruiting NCT00478114
Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) treatment 3 completed NCT00081614
A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma treatment 2 completed NCT03387514
Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies diagnostic 2 terminated NCT05661955
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. treatment 1 / 2 recruiting NCT05170555
Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617 diagnostic Not Available unknown_status NCT02315755
Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC No drug interventions Not Available Not Available completed NCT04322955
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition treatment 2 recruiting NCT05798455
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma No drug interventions treatment 1 / 2 not_yet_recruiting NCT00625755
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma No drug interventions treatment 1 / 2 completed NCT06129955
Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma treatment 2 not_yet_recruiting NCT01762150
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma treatment 2 completed NCT04413123
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC treatment 2 recruiting NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis No drug interventions Not Available Not Available recruiting NCT01598038
Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell Carcinoma No drug interventions treatment Not Available terminated NCT04831138
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma No drug interventions diagnostic Not Available enrolling_by_invitation NCT06076538
PET/MR for Characterization of Renal Masses (RMs) No drug interventions Not Available Not Available recruiting NCT04955743
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma treatment 2 recruiting NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT01115803
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors treatment 1 terminated NCT01665703
Imaging Correlates of Renal Cell Carcinoma Biological Features No drug interventions diagnostic Not Available completed NCT04987203
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma treatment 3 active_not_recruiting NCT04555603
Axitinib Therapy Management Study Not Available Not Available withdrawn NCT00862303
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma No drug interventions treatment 1 / 2 unknown_status NCT00001703
Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma treatment 2 terminated NCT01677390
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma treatment 1 terminated NCT01890590
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma No drug interventions treatment Not Available recruiting NCT06211790
Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma treatment 2 recruiting NCT05468190
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T No drug interventions treatment 1 recruiting NCT00330564
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow treatment 2 terminated NCT05548621
A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC) No drug interventions Not Available Not Available recruiting NCT05725421
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy No drug interventions treatment Not Available not_yet_recruiting NCT04623502
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy No drug interventions basic_science Not Available recruiting NCT03873402
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer treatment 3 active_not_recruiting NCT00087984
RNA-Loaded Dendritic Cell Cancer Vaccine No drug interventions treatment 1 / 2 completed NCT05285579
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer No drug interventions Not Available Not Available recruiting NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis treatment 1 / 2 recruiting NCT03699579
Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC No drug interventions Not Available Not Available completed NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT00258687
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma No drug interventions treatment 1 completed NCT04535687
Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma treatment 2 completed NCT03200587
Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) treatment 1 completed NCT00496587
Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma treatment 2 completed NCT01762033
A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma treatment 2 terminated NCT04596033
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy treatment 1 terminated NCT02626754
A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population treatment 2 terminated NCT04271254
PET/MR Characterization of Renal Cell Carcinomas No drug interventions diagnostic Not Available terminated NCT05501054
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma. treatment 1 / 2 recruiting NCT05534854
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes No drug interventions Not Available Not Available recruiting NCT03172754
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma treatment 1 / 2 active_not_recruiting NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT06020651
Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside No drug interventions basic_science Not Available recruiting NCT01625351
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas treatment 1 completed NCT02619253
Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma treatment 1 completed NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT01236053
Cancer in Patients With Gabapentin (GPRD) Not Available Not Available completed NCT00417677
A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma treatment 1 / 2 terminated NCT03141177
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma treatment 3 active_not_recruiting NCT05902377
68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma No drug interventions diagnostic 2 recruiting NCT00550277
LBH589 Treatment for Refractory Clear Cell Renal Carcinoma treatment 2 completed NCT00563147
A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma treatment 1 completed NCT03207347
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) treatment 2 completed NCT01566747
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 treatment 2 completed NCT05420545
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT03161145
A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread No drug interventions Not Available Not Available completed NCT00836745
Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent No drug interventions Not Available Not Available completed NCT05263245
The Pharmacological Effects of Using Cabozantinib With a Light Breakfast No drug interventions treatment 2 recruiting NCT01173445
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT03729245
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) treatment 3 terminated NCT04534998
Robotic-assisted vs. Open Partial Nephrectomy No drug interventions treatment 2 unknown_status NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) treatment 1 completed NCT00460798
SUTENT® In The First Line Treatment Of Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01063998
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma No drug interventions Not Available Not Available terminated NCT00944905
Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) No drug interventions treatment 1 completed NCT00556205
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma treatment 2 withdrawn NCT06285097
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors treatment 1 recruiting NCT03471897
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT02924597
Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage No drug interventions prevention Not Available unknown_status NCT05468697
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024) treatment 1 / 2 recruiting NCT03981497
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms No drug interventions Not Available Not Available recruiting NCT04438083
A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC) treatment 1 active_not_recruiting NCT04005183
Renal Cell Carcinoma Microenvironment Discovery Project No drug interventions Not Available Not Available active_not_recruiting NCT01834183
Tivozanib + Gemcitabine in Metastatic RCC treatment 2 withdrawn NCT01405183
Association Between Hepatitis C Infection and Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT00001683
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer treatment 1 completed NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors treatment 1 recruiting NCT02811861
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma treatment 3 active_not_recruiting NCT01441661
Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01502228
PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma other Not Available terminated NCT05744128
CD8 Minibody Repeatability Study diagnostic 2 recruiting NCT03097328
Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma treatment 2 completed NCT03291028
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma No drug interventions Not Available Not Available recruiting NCT00869011
Exercise for Patients With Renal Cell Cancer Receiving Sunitinib No drug interventions supportive_care 3 unknown_status NCT04301011
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors treatment 1 / 2 terminated NCT04609293
Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma Not Available Not Available unknown_status NCT05397093
ITIL-306 in Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02001493
Metabolomic Profiling in Renal Cell Carcinoma No drug interventions Not Available Not Available unknown_status NCT03297593
Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma treatment 2 active_not_recruiting NCT03709771
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease No drug interventions Not Available Not Available terminated NCT05810571
Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study No drug interventions diagnostic Not Available active_not_recruiting NCT02919371
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) treatment 1 / 2 unknown_status NCT00631371
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects treatment 3 completed NCT01829971
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection No drug interventions treatment 1 terminated NCT06318871
Memory-like Natural Killer (NK) Cell Therapy With N-803 in Patients With Renal Cell Carcinoma or Urothelial Carcinoma treatment 0 not_yet_recruiting NCT00126178
Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer treatment 3 terminated NCT04834778
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) No drug interventions treatment 1 completed NCT00672178
Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC) No drug interventions treatment 1 / 2 terminated NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT00420888
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma treatment 2 / 3 completed NCT01224288
Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble No drug interventions diagnostic 3 active_not_recruiting NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT03738488
3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement No drug interventions device_feasibility Not Available unknown_status NCT01997788
The Intrathecal Morphine for Nephrectomy treatment Not Available completed NCT04758507
Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma No drug interventions treatment 1 / 2 active_not_recruiting NCT02850809
Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors No drug interventions Not Available Not Available completed NCT04981509
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer treatment 2 recruiting NCT02645409
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma treatment Not Available completed NCT01924156
DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma No drug interventions treatment 1 / 2 unknown_status NCT00625456
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors treatment 1 completed NCT03744585
Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive Non-interventional Study of 2 Cohorts. No drug interventions Not Available Not Available completed NCT03176485
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors No drug interventions prevention Not Available completed NCT06265285
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program No drug interventions health_services_research 2 recruiting NCT05733715
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma treatment 0 recruiting NCT02787915
DC1s-CTL Cellular Therapy for Renal Cell Carcinoma No drug interventions treatment 1 / 2 unknown_status NCT05621837
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy No drug interventions Not Available Not Available unknown_status NCT01026337
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer Not Available Not Available completed NCT03827837
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors treatment 2 unknown_status NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers treatment 2 / 3 recruiting NCT00056537
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer treatment 1 completed NCT03464032
A Study of BCD-135 in Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT00606632
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody No drug interventions diagnostic 3 completed NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population No drug interventions Not Available Not Available active_not_recruiting NCT02947152
HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma No drug interventions treatment 1 terminated NCT01392352
HYPAZ: Hypertension Induced by Pazopanib basic_science 2 terminated NCT01176500
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors diagnostic 1 / 2 withdrawn NCT03319459
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors treatment 1 completed NCT00827359
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma treatment 2 completed NCT00903175
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT02829775
A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies treatment 2 / 3 completed NCT00918775
Follow-up After Metastasectomy in Patients With Kidney Cancer No drug interventions Not Available Not Available active_not_recruiting NCT06010875
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT00970970
Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease No drug interventions Not Available Not Available completed NCT02338570
Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) other 4 terminated NCT00715442
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC) treatment 2 active_not_recruiting NCT02133742
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer treatment 1 completed NCT04787042
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 treatment 1 / 2 active_not_recruiting NCT01984242
A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma treatment 2 completed NCT05800106
A Bioequivalence Study of Sunitinib Malate Capsules. treatment 1 completed NCT00975806
Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma treatment 1 / 2 terminated NCT01836406
Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy prevention Not Available completed NCT05030506
A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010) treatment 1 active_not_recruiting NCT04402749
The Incidence of Pulmonary Embolism During Nephrectomy No drug interventions Not Available Not Available completed NCT04892849
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy No drug interventions Not Available Not Available recruiting NCT00556049
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma treatment 2 completed NCT05375136
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients No drug interventions Not Available Not Available completed NCT03393936
Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma No drug interventions treatment 1 / 2 unknown_status NCT01147536
Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence treatment 2 terminated NCT05168436
A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal No drug interventions Not Available Not Available completed NCT03829436
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers treatment 1 completed NCT04244136
Residual Normal Renal Parenchymal and Tumor Volume in Tumor Surgeries No drug interventions Not Available Not Available unknown_status NCT01227213
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01361113
Neoadjuvant Pazopanib in Renal Cell Carcinoma treatment 2 completed NCT00980213
Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland Not Available Not Available completed NCT04804813
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma Not Available Not Available completed NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT01399918
Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC) treatment 2 completed NCT06005818
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) treatment 2 recruiting NCT03894618
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 completed NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT06090318
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss treatment 1 / 2 withdrawn NCT02849119
Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy No drug interventions treatment Not Available unknown_status NCT01100619
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors treatment 1 completed NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers treatment 1 completed NCT03554434
An Expanded Access Program for AM0010 (Pegilodecakin) Not Available Not Available no_longer_available NCT02440334
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation diagnostic 2 completed NCT02399124
Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma No drug interventions treatment Not Available active_not_recruiting NCT05949424
OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults treatment 4 not_yet_recruiting NCT01138124
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) Not Available Not Available completed NCT03809624
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer treatment 1 active_not_recruiting NCT03598816
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma treatment 2 withdrawn NCT05149196
Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy No drug interventions prevention Not Available not_yet_recruiting NCT03786796
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations treatment 2 recruiting NCT05969496
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus treatment 2 recruiting NCT00684996
Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer treatment 1 / 2 terminated NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT02326558
Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma No drug interventions treatment Not Available completed NCT02596035
An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma other 4 completed NCT06182735
CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma treatment 1 recruiting NCT02928263
Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents No drug interventions Not Available Not Available withdrawn NCT04804163
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery No drug interventions other 0 completed NCT01914263
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection No drug interventions treatment 1 unknown_status NCT00026663
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance No drug interventions Not Available Not Available completed NCT00485563
A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma treatment 2 terminated NCT03226886
TRACERx Renal CAPTURE Sub-study No drug interventions Not Available Not Available unknown_status NCT03189186
Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas treatment 1 withdrawn NCT06536439
Planning Operative Strategy Using a Digital Renal Artery Clamping Tool No drug interventions treatment Not Available recruiting NCT00730639
A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies treatment 1 completed NCT04629339
Study of INCB086550 in Select Solid Tumors treatment 2 terminated NCT03177239
Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) treatment 2 unknown_status NCT04006522
89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma diagnostic 2 recruiting NCT03047525
Study of DC-CTL Combined With CIK for Advanced Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT04508725
Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) diagnostic Not Available active_not_recruiting NCT06265025
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT01114230
A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer No drug interventions treatment 1 completed NCT06049030
A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma No drug interventions treatment 1 not_yet_recruiting NCT00923130
Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer treatment 2 completed NCT00557830
Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma treatment 2 terminated NCT04707248
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors No drug interventions treatment 1 recruiting NCT03685448
ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) treatment 2 unknown_status NCT02264548
A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy No drug interventions treatment 1 completed NCT04503148
Anesthesia and Cancer Study: Renal Cell Carcinoma prevention Not Available active_not_recruiting NCT04213157
Laparoscopic Partial Nephrectomy for cT1 Tumors No drug interventions Not Available Not Available completed NCT04495257
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) treatment 1 active_not_recruiting NCT02386826
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme treatment 1 completed NCT03845166
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors treatment 1 active_not_recruiting NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) treatment 1 / 2 recruiting NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients other 2 recruiting NCT02718066
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01014065
A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) No drug interventions Not Available Not Available completed NCT01441765
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine treatment 2 terminated NCT05592665
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology No drug interventions health_services_research Not Available recruiting NCT02307474
A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer treatment Not Available withdrawn NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers treatment 1 / 2 completed NCT01585974
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT02410174
To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors No drug interventions treatment 1 terminated NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT00749320
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC) No drug interventions diagnostic Not Available completed NCT00923520
A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies No drug interventions treatment 1 completed NCT00884520
An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 Not Available 0 completed NCT01482520
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01210482
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed NCT00876382
Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT05124431
Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma treatment 2 not_yet_recruiting NCT00006431
Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA No drug interventions treatment 1 unknown_status NCT03576131
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 terminated NCT01975831
A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab treatment 1 completed NCT02853331
Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426) treatment 3 active_not_recruiting NCT06307431
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) treatment 2 recruiting NCT04631731
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity No drug interventions diagnostic 1 / 2 recruiting NCT01354431
BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC) treatment 2 completed NCT03693573
A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma treatment 3 withdrawn NCT05243173
Biomarkers of Response to Systemic Treatments in FH-deficient RCC No drug interventions Not Available Not Available unknown_status NCT03324373
Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC) treatment 1 active_not_recruiting NCT03624673
Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell Carcinoma No drug interventions treatment Not Available active_not_recruiting NCT02131376
Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy No drug interventions treatment Not Available terminated NCT03427476
CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma diagnostic 1 completed NCT00788060
A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma treatment 1 completed NCT03173560
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma treatment 2 active_not_recruiting NCT02446860
A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR) treatment 2 unknown_status NCT04495894
Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma other 0 recruiting NCT00635791
Phase I Study of Vorinostat and Sorafenib in Advanced Cancer treatment 1 completed NCT03511391
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors treatment 2 completed NCT02071862
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors treatment 1 completed NCT03063762
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC) treatment 1 completed NCT01339962
Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2. No drug interventions Not Available Not Available completed NCT00176280
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma treatment 2 withdrawn NCT04873180
Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01649180
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma treatment 2 terminated NCT06424080
Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors. No drug interventions treatment Not Available recruiting NCT04628780
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 terminated NCT03552380
Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma treatment 2 terminated NCT04601129
Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery No drug interventions Not Available Not Available recruiting NCT00610389
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors No drug interventions treatment 2 unknown_status NCT02143492
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC No drug interventions Not Available Not Available completed NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors treatment 2 active_not_recruiting NCT01762592
REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT diagnostic 3 withdrawn NCT01297244
A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma treatment 2 completed NCT03334344
Using Virtual Reality (VR) Models for Preoperative Planning No drug interventions treatment Not Available completed NCT03435640
REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies treatment 1 / 2 terminated NCT00934440
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma treatment 1 / 2 terminated NCT00718367
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens No drug interventions Not Available Not Available completed NCT03374267
Registry Platform Urologic Cancer No drug interventions Not Available Not Available recruiting NCT04074967
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab treatment 1 / 2 active_not_recruiting NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT03748901
PD-L1 Expression in Japanese Renal Cell Carcinoma Patients No drug interventions Not Available Not Available completed NCT05229601
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT05805501
A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma treatment 2 recruiting NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers treatment 1 recruiting NCT04637204
Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England Not Available Not Available completed NCT02809404
Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study) Not Available Not Available completed NCT04933604
LPN in Patients With High-complex Renal Tumors No drug interventions Not Available Not Available completed NCT01404104
Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma treatment Not Available completed NCT02527304
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery No drug interventions treatment Not Available completed NCT00777504
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors No drug interventions treatment 4 unknown_status NCT05256472
A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma treatment 2 recruiting NCT03419572
Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01711268
Sunitinib Drug Levels and Outcomes in Kidney Cancer No drug interventions Not Available Not Available unknown_status NCT04268368
Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors No drug interventions Not Available Not Available unknown_status NCT05789069
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT06376669
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma No drug interventions treatment 2 not_yet_recruiting NCT00384969
Sorafenib and RAD001 Renal Cell Carcinoma treatment 1 completed NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT00923169
Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma) No drug interventions treatment 1 completed NCT05148546
Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer treatment 2 recruiting NCT01613846
Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II) treatment 3 completed NCT02232646
A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies treatment 2 withdrawn NCT03663946
A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread No drug interventions Not Available Not Available completed NCT04416646
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma Not Available Not Available active_not_recruiting NCT00561912
Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma treatment 2 terminated NCT03633110
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine treatment 1 / 2 completed NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT00979381
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor No drug interventions Not Available Not Available completed NCT01472081
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) treatment 1 completed NCT05005195
Yorkshire Kidney Screening Trial No drug interventions screening Not Available active_not_recruiting NCT00830895
RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC) treatment 2 completed NCT02446795
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial treatment 1 / 2 unknown_status NCT03874455
Tazemetostat Expanded Access Program for Adults With Solid Tumors Not Available Not Available no_longer_available NCT01773655
Clinical and Histopathologic Characteristics of BAP1 Mutations No drug interventions Not Available Not Available completed NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies treatment 1 completed NCT02080650
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) No drug interventions device_feasibility Not Available completed NCT03775850
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors treatment 1 completed NCT06342323
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy No drug interventions Not Available Not Available recruiting NCT03776123
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients No drug interventions Not Available Not Available completed NCT06255223
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy No drug interventions treatment 2 recruiting NCT05808608
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma treatment 1 / 2 not_yet_recruiting NCT02496208
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors treatment 1 active_not_recruiting NCT00001238
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders No drug interventions Not Available Not Available recruiting NCT00491738
A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R) treatment 2 terminated NCT01254838
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma No drug interventions Not Available 1 completed NCT06580938
A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer treatment 1 not_yet_recruiting NCT04022343
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer treatment 2 active_not_recruiting NCT01473043
Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment Not Available Not Available no_longer_available NCT01391143
Safety Study of MGA271 in Refractory Cancer treatment 1 completed NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT02390843
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors treatment 1 completed NCT00717743
T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY) No drug interventions Not Available Not Available completed NCT02537743
Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT02855203
Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours treatment 1 / 2 completed NCT01771003
Remote Ischemia Pre-Conditioning in Patients Undergoing Partial Nephrectomy No drug interventions prevention Not Available terminated NCT03108703
Assessment of QoL and Outcomes With SBRT for RCC No drug interventions treatment Not Available active_not_recruiting NCT03637803
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors treatment 1 / 2 terminated NCT05867303
A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02370290
Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer No drug interventions Not Available Not Available completed NCT01442090
Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy treatment 2 completed NCT02216890
Safety Study of SGN-CD70A in Cancer Patients No drug interventions treatment 1 completed NCT06101290
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) No drug interventions treatment Not Available recruiting NCT03928964
MEtatastic Renal Carcinoma LINes No drug interventions Not Available Not Available unknown_status NCT01206764
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. treatment 4 completed NCT05650164
Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) Not Available Not Available completed NCT01806064
Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma treatment 1 / 2 terminated NCT04213664
Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma. No drug interventions Not Available Not Available unknown_status NCT00448721
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer treatment 2 completed NCT01358721
Phase I Biomarker Study (BMS-936558) basic_science 1 completed NCT02420821
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) treatment 3 completed NCT04429321
Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary treatment 1 terminated NCT02325921
MRI in Renal Tumors No drug interventions Not Available Not Available completed NCT05354102
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 treatment 1 active_not_recruiting NCT03541902
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma treatment 2 active_not_recruiting NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT06391879
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma No drug interventions Not Available Not Available recruiting NCT03421418
Using Virtual Reality (VR) Models for Preoperative Planning - UNC No drug interventions treatment Not Available completed NCT03534206
Using Virtual Reality (VR) Models for Preoperative Planning - University of Tennessee No drug interventions treatment Not Available completed NCT03542565
Using Virtual Reality (VR) Models for Preoperative Planning - JWCI No drug interventions treatment Not Available completed NCT03556943
Using Virtual Reality (VR) Models for Preoperative Planning - Mayo Clinic No drug interventions treatment Not Available completed NCT03666104
Using Virtual Reality (VR) Models for Preoperative Planning - Mount Sinai No drug interventions treatment Not Available completed NCT04545827
Study to Evaluate the Safety of IMM-01 in Patients With Advanced Solid Tumours basic_science 1 not_yet_recruiting NCT03889782
High Dose IL-2 in Combination With Anti-PD-1 in Metastatic Melanoma and Renal Cell Carcinoma treatment 2 not_yet_recruiting NCT01420601
Temsirolimus (Torisel) Special Investigation (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed